15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 24 firms covering Intuitive Surgical Inc, 21 rate it Buy or better, 3 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets range widely, $375.00 to $931.00 (about 2.5x), a sign of real disagreement on valuation. The average target of $531.83 sits 52% above the current $349.99. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 16 to 21 over recent months. On the fundamentals, the Street sees consensus EPS building from about $2.84 next quarter toward $12.07 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS24 ratings
Strong Buy
Strong Buy00%
Buy2188%
Hold313%
Sell00%
Strong Sell00%
Based on 24 analysts giving stock ratings to Intuitive Surgical Inc.
As of Sep, 21 of 24 firms rate ISRG a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
ISRG EPS & revenue forecast
EPS · NEXT QUARTER
$2.84
Range $2.72 – $3.02 · 23 analysts · +12% YoY
Next period, 23 analysts expect Intuitive Surgical Inc to earn $2.84 a share (range $2.72 – $3.02), versus $2.53 a year earlier. Full-year consensus is $10.79, growing to $12.07 the year after.
REVENUE · NEXT QUARTER
$3.2B
Range $3.2B – $3.3B · 23 analysts · +12% YoY
Revenue is expected to reach $3.2B (range $3.2B – $3.3B), +12.2% year-over-year. Full-year consensus is $11.8B, rising to $13.2B next year.
Top analysts covering Intuitive Surgical Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ISRG.
#1
Anthony Petrone
Mizuho · Rank #86
Hold
$400.00+14.3% to target
Overall win rate
46%
+ Follow
#2
JB
Jayson Bedford
Raymond James · Rank #196
Buy
$483.00+38.0% to target
Overall win rate
42%
+ Follow
#3
Joanne Wuensch
Citigroup
Buy
No targeton ISRG
Coverage
—
+ Follow
#4
Ryan Zimmerman
BTIG
Buy
$469.00+34.0% to target
Coverage
—
+ Follow
#5
Lee Hambright
Bernstein
Buy
$685.00+95.7% to target
Coverage
—
+ Follow
ISRG stock forecast FAQ
What is ISRG's average 12-month price target?+
The 22 analysts with a live target average $531.83 for Intuitive Surgical Inc over the next 12 months, ranging from a $931.00 high to a $375.00 low.
Is ISRG stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 24 analyst ratings, 21 are Buy or Strong Buy, 3 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for ISRG?+
The Street-high target is $931.00 (HSBC), and the Street-low is $375.00 (Evercore ISI Group). The average of all 22 active targets is $531.83.
How many Wall Street analysts cover ISRG?+
24 analysts have an active rating on Intuitive Surgical Inc, and 22 firms carry a live 12-month price target.
Who is the most accurate analyst covering ISRG?+
Among analysts who currently cover ISRG, Anthony Petrone of Mizuho has the strongest overall Quantellect track record (Rank #86). Their current call is Hold with a $400.00 target.
What is Intuitive Surgical Inc's projected EPS for next quarter?+
The consensus estimate is $2.84 per share (range $2.72 – $3.02) across 23 analysts. Full-year EPS is projected at $10.79, rising to $12.07 the following year.
How much revenue is Intuitive Surgical Inc expected to report next quarter?+
Consensus revenue is $3.2B (range $3.2B – $3.3B). Full-year revenue is projected at $11.8B, growing to $13.2B next year.
Have analysts been upgrading or downgrading ISRG lately?+
As of Sep, 21 of 24 firms rate ISRG a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ISRG calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
UBS
BMO Capital
